Clinical Trials Logo

Clinical Trial Summary

This research is about a genital disease known as Lichem Sclerosus and Atrophic. It mainly affects women over 18 years of age. The treatment will involve injections of a medicine that contains cortisone, using two different methods: with a syringe and a needle or with a tattoo machine. Before and after treatment, they will see if women feel pain, itching, burning, scratching or difficulty having sexual intercourse.


Clinical Trial Description

There is evidence that injectable triamcinolone has an effect on reducing the symptoms of lichen sclerosus and atrophic. After randomizing the vulva, the vulva will be anesthetized with lidocaine infiltrations. After 15 minutes, interventions will begin. Triamcinolone will be injected using two different techniques: syringes & needles in one side and with tattoo machine (MMP technique) in other side. The outcomes will be evaluated according to the criteria of pain, itching, burning, itching and difficulty in sexual penetration ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06079645
Study type Interventional
Source Clinica Dermatologica Arbache ltda
Contact SAMIR ARBACHE, PHD MD
Phone +55 12 981221011
Email samir@dermocentro.com.br
Status Recruiting
Phase Phase 4
Start date October 20, 2023
Completion date April 2, 2025